Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Controlled Trial: the Effect of a Medical Grade Honey Formulation (L-Mesitran) on Clinical Symptoms of Recurrent Vulvovaginal Candidiasis

NCT05367089 is registered in ClinicalTrials.gov with Maastricht University Medical Center as lead sponsor.

NCT NCT05367089
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05367089 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Controlled Trial: the Effect of a Medical Grade Honey Formulation (L-Mesitran) on Clinical Symptoms of Recurrent Vulvovaginal Candidiasis
Lead sponsor
Maastricht University Medical Center
Phase
Phase 3
Overall status
Recruiting
Start date
August 22, 2022
Completion date
April 22, 2027
Enrollment
252 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

candidiasis, vulvovaginal, recurrent candidiasis of vagina